华盛昌(002980) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 reached ¥227,768,210.77, an increase of 39.32% year-over-year[2] - Net profit attributable to shareholders was ¥45,685,468.22, up 32.72% compared to the same period last year[2] - Net profit excluding non-recurring items was ¥43,283,125.29, reflecting a 37.94% increase year-over-year[2] - Basic earnings per share (EPS) was ¥0.41, representing a 78.26% increase from the previous year[2] - The total operating revenue for the third quarter of 2024 reached RMB 560,818,902.54, an increase of 14.25% compared to RMB 490,674,685.30 in the same period last year[19] - The company's net profit attributable to shareholders increased to RMB 313,005,527.47, compared to RMB 282,616,296.78 in the previous period, showing a growth of 10.77%[18] - The net profit attributable to shareholders of the parent company for Q3 2024 was 109,881,970.69, an increase from 91,030,035.10 in Q3 2023, representing a growth of approximately 20.6%[21] - The total profit for Q3 2024 was 121,877,489.83, compared to 97,912,589.01 in Q3 2023, indicating an increase of around 24.4%[20] - The company's total comprehensive income for Q3 2024 was 108,917,546.46, compared to 90,347,910.54 in Q3 2023, reflecting an increase of approximately 20.5%[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,367,298,107.92, a 1.09% increase from the end of the previous year[2] - The total liabilities increased to RMB 312,877,523.15 from RMB 293,777,311.55, reflecting an increase of 6.3%[18] - The company's cash and cash equivalents decreased to RMB 236,452,876.56 from RMB 276,380,780.76 at the beginning of the period, reflecting a decline of 14.43%[16] - Accounts receivable increased significantly to RMB 180,793,796.52, up from RMB 121,797,285.51, marking an increase of 48.3%[17] - Inventory rose to RMB 288,166,833.42, compared to RMB 268,765,799.42 at the beginning of the period, indicating an increase of 7.25%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,543, with the top 10 shareholders holding a combined 72.88% of shares[7] - Yuan Jianmin, the largest shareholder, holds 54.00% of shares, totaling 72,000,000 shares[7] - The company has a total of 18,000,000 unrestricted shares held by Yuan Jianmin[10] - The company has engaged in share buyback activities, with announcements made on February 8 and May 31, 2024[13] - As of September 30, 2024, the company has repurchased 1,518,100 shares, accounting for 1.14% of the total share capital, with a total transaction amount of RMB 33,380,694.40[15] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥149,267,030.06, a 33.17% increase year-over-year[2] - Cash flow from operating activities for Q3 2024 was 551,400,647.90, compared to 533,486,475.54 in Q3 2023, showing a growth of about 3.4%[22] - The net cash flow from operating activities for Q3 2024 was CNY 149,267,030.06, an increase from CNY 112,088,158.93 in Q3 2023, reflecting a growth of approximately 33.2%[23] - The total cash inflow from operating activities was CNY 599,017,000.60, compared to CNY 572,394,477.81 in the same period last year, indicating a year-over-year increase of about 4.4%[23] - The cash outflow from operating activities totaled CNY 449,749,970.54, slightly down from CNY 460,306,318.88 in Q3 2023, showing a decrease of approximately 2.4%[23] Expenses - Sales expenses rose by 42.69% to ¥48,963,115.25, attributed to increased investment in sales channels and teams[6] - Total operating costs for Q3 2024 were 438,206,698.09, up from 398,285,750.74 in Q3 2023, indicating an increase of about 10%[20] - Research and development expenses for Q3 2024 were 55,827,768.93, slightly up from 55,219,020.29 in Q3 2023, reflecting a year-over-year increase of 1.1%[20] Corporate Developments - The company received EU MDR certification for its electronic thermometers, blood pressure monitors, and pulse oximeters on January 31, 2024[13] - The company plans to establish a subsidiary in Vietnam, with the announcement made on June 12, 2024[13] - The company has announced a change in registered capital and amendments to its articles of association on February 22, 2024[13] - The company is involved in foreign exchange hedging activities as of April 20, 2024[13] - The company has reported a provision for asset impairment for the year 2023 on April 20, 2024[13] Other Financial Metrics - The company's operating profit for Q3 2024 was 122,133,633.18, compared to 97,907,823.70 in Q3 2023, marking an increase of approximately 24.7%[20] - The basic earnings per share for Q3 2024 was 0.98, up from 0.65 in Q3 2023, representing an increase of approximately 50.8%[21] - Other comprehensive income after tax for Q3 2024 was -1,583,217.27, compared to -1,151,525.70 in Q3 2023, showing a decline in other comprehensive income[21] - The net cash flow from investing activities was CNY 2,569,460.12, a significant decrease from CNY 42,699,972.62 in Q3 2023[23] - The cash inflow from investing activities was CNY 831,645,701.36, down from CNY 1,295,900,153.27 in the previous year, representing a decline of about 35.8%[23] - The cash outflow from investing activities was CNY 829,076,241.24, compared to CNY 1,253,200,180.65 in Q3 2023, indicating a decrease of approximately 33.8%[23] - The net cash flow from financing activities was -CNY 193,930,718.01, worsening from -CNY 16,957,123.79 in the same quarter last year[23] - The total cash and cash equivalents at the end of Q3 2024 were CNY 235,652,876.56, down from CNY 335,118,592.73 in Q3 2023, reflecting a decrease of approximately 29.6%[24] - The company reported a cash inflow from financing activities of CNY 1,864,815.84, significantly lower than CNY 65,218,325.15 in Q3 2023, indicating a decline of about 97.1%[23] - The cash outflow for financing activities was CNY 195,795,533.85, compared to CNY 82,175,448.94 in the previous year, showing an increase of approximately 138.5%[23]